Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
出版年份 2018 全文链接
标题
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
作者
关键词
-
出版物
Multiple Sclerosis Journal
Volume -, Issue -, Pages 135245851881938
出版商
SAGE Publications
发表日期
2018-12-20
DOI
10.1177/1352458518819380
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
- (2018) Christian Barro et al. BRAIN
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis
- (2018) Nelly Siller et al. Multiple Sclerosis Journal
- Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study
- (2018) Jeffrey J Bazarian et al. LANCET NEUROLOGY
- Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
- (2017) Lenka Novakova et al. NEUROLOGY
- Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa
- (2016) Jens Kuhle et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
- (2016) Jens Kuhle et al. Multiple Sclerosis Journal
- Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future
- (2014) Itay Raphael et al. Expert Review of Clinical Immunology
- Acute Biomarkers of Traumatic Brain Injury: Relationship between Plasma Levels of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein
- (2013) Ramon Diaz-Arrastia et al. JOURNAL OF NEUROTRAUMA
- Immunosuppressive therapy reduces axonal damage in progressive multiple sclerosis
- (2013) Markus Axelsson et al. Multiple Sclerosis Journal
- Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis
- (2012) Timucin Avsar et al. Multiple Sclerosis Journal
- Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis
- (2012) M. Tutuncu et al. Multiple Sclerosis Journal
- Age and disability accumulation in multiple sclerosis
- (2011) A. Scalfari et al. NEUROLOGY
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab
- (2010) Martin Gunnarsson et al. ANNALS OF NEUROLOGY
- Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
- (2010) M. Axelsson et al. JOURNAL OF NEUROLOGY
- Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations
- (2010) David M Rissin et al. NATURE BIOTECHNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now